Home › Myelofibrosis › Tennessee › Nashville

Pag-aaral pangklinika para sa Myelofibrosis sa Nashville, TN

9 pag-aaral para sa Myelofibrosis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Nashville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Nagre-recruitPhase 1/2

Tri-Star Centennial Medical Center, Nashville
Vanderbilt University, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Nagre-recruitPhase 3

Vanderbilt-Ingram Cancer Center (VICC)-Nashville, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07623161

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Nagre-recruitPhase 1

Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
Tristar BMT, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Nagre-recruitPhase 2

Vanderbilt University/Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06661915

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1

Tristar Bmt/Tcto, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07441694

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Nagre-recruitPhase 2

GSK Investigational Site, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06517875

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Nashville

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Nagre-recruitPhase 3

Tennessee Oncology, Nashville
Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT06479135

Pag-aaral para sa Myelofibrosis sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.